Novo Nordisk | NVO - Kapitalizacja Rynkowa





Kapitalizacja Rynkowa Zmiana Data
ANI Pharmaceuticals USD 1.75B 24M 2026-03
Aurora Cannabis CAD 193.82M 133.39M 2026-03
Bristol-Myers Squibb USD 117.66B 6.17B 2026-06
Canopy Growth CAD 557.13M 99.33M 2026-03
Corcept Therapeutics USD 9.33B 5.02B 2026-06
Drreddys Laboratories INR 11.07B 619M 2026-03
Eli Lilly USD 869.02B 146.97B 2026-03
GlaxoSmithKline GBP 80.14B 3.66B 2026-06
Merck USD 297.1B 35.84B 2026-03
Nektar Therapeutics USD 13.12B 12.26B 2026-07
Novartis USD 240.59B 67.17B 2026-06
Novo Nordisk A/S DKK 1.03T 421.31B 2026-03
Pacira USD 915M 149M 2026-03
Perrigo USD 1.31B 604M 2026-03
Phibro Animal Health USD 1.51B 126M 2025-12
Prestige Brands USD 2.8B 161M 2026-03
Sanofi EUR 91.15B 9.12B 2026-06
Supernus Pharmaceuticals USD 2.98B 126M 2026-03
Zoetis USD 49.71B 5.74B 2026-03